MR spectroscopy differentiation between high and low grade astrocytomas: A comparison between paediatric and adult tumours

European Journal of Paediatric Neurology

Volumn 15, Issue 3, 2011, Pages 214-221

  Porto, Luciana ^a,b   Kieslich, Matthias ^a   Franz, Kea ^a   Lehrnbecher, Thomas ^a   Zanella, Friedhelm ^a   Pilatus, Ulrich ^a   Hattingen, Elke ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

1H MR spectroscopy; Astrocytomas; Children; Choline; N Acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GLIOMA; GROUPS BY AGE; HEMODYNAMIC MONITORING; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 79955482759     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2010.11.003     Document Type: Article

References (42)

1. T.B. Johannesen, F. Langmark, and K. Lote Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumours were diagnosed between 1970 and 1993 J Neurosurg 99 2003 854 862 (Pubitemid 37314921)
2. M.J. van den Bent, D. Afra, and O. de Witte Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial Lancet 366 2005 985 990 (Pubitemid 41323034)
3. M. Bernstein, and A.G. Parrent Complications of CT-guided stereotactic biopsy of intra-axial brain lesions J Neurosurg 81 1994 165 168 (Pubitemid 24237991)
4. X. Yu, Z. Liu, and Z. Tian Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases Stereotact Funct Neurosurg 75 2000 103 108 (Pubitemid 33151573)
5. M. Law, M. Hamburger, and G. Johnson Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging Technol Cancer Res Treat 3 2004 557 565 [Review] (Pubitemid 40023545)
6. A. Stadlbauer, S. Gruber, and C. Nimsky Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging Radiology 238 2006 958 969 (Pubitemid 43289928)
7. T.R. McKnight, K.R. Lamborn, T.D. Love, M.S. Berger, S. Chang, and W.P. Dillon Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas J Neurosurg 106 2007 660 666 (Pubitemid 46536464)
8. 1H-chemical-shift imaging of choline Stereotact Funct Neurosurg 86 2008 300 307
9. C. Daumas-Duport, M.L. Tucker, and H. Kolles Oligodendrogliomas. II. A new grading system based on morphological and imaging criteria J Neurooncol 34 1997 61 78 (Pubitemid 27270252)
10. F. Mihara, Y. Numaguchi, M. Rothman, S. Sato, and M.S. Fiandaca MR imaging of adult supratentorial astrocytomas: an attempt of semi-automatic grading Radiat Med 13 1995 5 9
11. A. Pierallini, M. Bonamini, and A. Bozzao Supratentorial diffuse astrocytic tumours: proposal of an MRI classification Eur Radiol 7 1997 395 399 (Pubitemid 127538637)
12. J.N. Scott, P.M. Brasher, R.J. Sevick, N.B. Rewcastle, and P.A. Forsyth How often are nonenhancing supratentorial gliomas malignant? a population study Neurology 59 2002 947 949
13. M.L. White, Y. Zhang, P. Kirby, and T.C. Ryken Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 26 2005 784 790 (Pubitemid 43079768)
14. C. Senft, E. Hattingen, U. Pilatus, K. Franz, A. Schänzer, and H. Lanfermann Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values Neurosurgery 65 2009 908 913
15. S. Herminghaus, T. Dierks, U. Pilatus, W. Möller-Hartmann, J. Wittsack, and G. Marquardt Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data J Neurosurg 98 2003 74 81 (Pubitemid 36050450)
16. S.W. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679 (Pubitemid 23360802)
17. E. Hattingen, P. Raab, K. Franz, H. Lanfermann, M. Setzer, and R. Gerlach Prognostic value of choline and creatine in WHO grade II gliomas Neuroradiology 50 2008 759 767
18. D. Wiedermann, N. Schuff, G.B. Matson, B.J. Soher, A.T. Du, and A.A. Maudsley Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability Magn Reson Imaging 19 2001 1073 1080
19. G. Tedeschi, N. Lundbom, R. Raman, S. Bonavita, J.H. Duyn, and J.R. Alger Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study J Neurosurg 87 1997 516 524 (Pubitemid 27430397)
20. I. Catalaa, R. Henry, W.P. Dillon, E.E. Graves, T.R. McKnight, and Y. Lu Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas NMR Biomed 19 2006 463 475 (Pubitemid 43997765)
21. P. Zonari, P. Baraldi, and G. Crisi Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging Neuroradiology 49 2007 795 803 (Pubitemid 47497767)
22. P.B. Barker N-acetyl-L-asparte-a neuronal marker? Ann Neurol 49 2001 423 424
23. R.K. Gupta, T.F. Cloughesy, U. Sinha, J. Garakian, J. Lazareff, and G. Rubino Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma J Neurooncol 50 2000 215 226 (Pubitemid 32192873)
24. R.J. Gillies, J.A. Barry, and B.D. Ross In vitro and in vivo 13 C and 31 P NMR analyses of phosphocholine metabolism in rat glioma cells Magn Reson Med 32 1994 310 318 (Pubitemid 24274909)
25. S. Herminghaus, U. Pilatus, W. Moller-Hartmann, P. Raab, H. Lanfermann, and W. Schlote Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors NMR Biomed 15 2002 385 392
26. A. Panigrahy, M.D. Nelson Jr., J.L. Finlay, R. Sposto, M.D. Krieger, and F.H. Gilles Metabolism of diffuse intrinsic brainstem gliomas in children Neuro Oncol 10 2008 32 44 (Pubitemid 351250898)
27. K.K. Bhakoo, S.R. Williams, C.L. Florian, H. Land, and M.D. Noble Immortalization and transformation are associated with specific alterations in choline metabolism Cancer Res 56 1996 4630 4635 (Pubitemid 26338062)
28. A.A. Tzika Proton magnetic resonance spectroscopic imaging as a cancer biomarker for paediatric brain tumours Int J Oncol 32 2008 517 526 (Pubitemid 351330457)
29. 1H-MRSI in untreated paediatric brain tumours Magn Reson Med 53 2005 22 29 (Pubitemid 40110473)
30. 1H brain tumor spectra: a multicenter study Magn Reson Med 49 2003 29 36 (Pubitemid 36042331)
31. R. Hourani, A. Horská, S. Albayram, L.J. Brant, E. Melhem, and K.J. Cohen Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumours in children J Magn Reson Imaging 23 2006 99 107 (Pubitemid 43191061)
32. K.J. Marcus, L.G. Astrakas, D. Zurakowski, M.K. Zarifi, D. Mintzopoulos, and T.Y. Poussaint Predicting survival of children with CNS tumours using proton magnetic resonance spectroscopic imaging biomarkers Int J Oncol 30 2007 651 657
33. A.A. Tzika, S. Vajapeyam, and P.D. Barnes Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumours: preliminary observations AJNR Am J Neuroradiol 18 1997 203 218 (Pubitemid 27082196)
34. A.A. Tzika, L.G. Astrakas, M.K. Zarifi, D. Zurakowski, T.Y. Poussaint, and L. Goumnerova Spectroscopic and perfusion magnetic resonance imaging predictors of progression in paediatric brain tumours Cancer 15 2004 1246 1256 (Pubitemid 38325953)
35. K.E. Warren, J.A. Frank, J.L. Black, R.S. Hill, J.H. Duyn, and A.A. Aikin Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumours J Clin Oncol 18 2000 1020 1026 (Pubitemid 30123778)
36. 1H-MRSI and progression-free survival in patients with WHO grades II and III gliomas Neurol Res 32 2010 593 602
37. B.J. Fisher, C.C. Leighton, O. Vujovic, D.R. Macdonald, and L. Stitt Results of a policy of surveillance alone after surgical management of paediatric low grade gliomas Int J Radiat Oncol Biol Phys 51 2001 704 710
38. K. Kamada, K. Houkin, Y. Iwasaki, H. Abe, and T. Kashiwaba In vivo proton magnetic resonance spectroscopy for metabolic changes of human brain edema Neurol Med Chir 34 1994 676 681 (Pubitemid 24332092)
39. K. Kamada, K. Houkin, K. Hida, H. Matsuzawa, Y. Iwasaki, and H. Abe Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time Magn Reson Med 31 1994 537 540 (Pubitemid 24129948)
40. P. Chumas, B. Condon, D. Oluoch-Olunya, S. Griffiths, D. Hadley, and G. Teasdale Early changes in peritumorous oedema and contralateral white matter after dexamethasone: a study using proton magnetic resonance spectroscopy J Neurol Neurosurg Psychiatr 62 1997 590 595 (Pubitemid 27281261)
41. A. Laprie, I. Catalaa, E. Cassol, T.R. McKnight, D. Berchery, and D. Marre Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study Int J Radiat Oncol Biol Phys 70 2008 773 781 (Pubitemid 351199728)
42. A. Laprie, A. Pirzkall, D.A. Haas-Kogan, S. Cha, A. Banerjee, and T.P. Le Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy Int J Radiat Oncol Biol Phys 62 2005 20 31 (Pubitemid 40591919)